B2M and Leigh syndrome: Although β2-microglobulin (β2M) mutations leading to the loss of MHC class I antigen presentation to CD8+ T cells have been documented in LS patients [46], no grade IV metastatic MSI-H tumors presented mutations in this gene suggesting a crucial role for β2M in the metastatic process [47].